TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: headache-related disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrent stroke or systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Contacting a Papanicolaou test referral
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year disease-specific survival (DSS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of acute graft‐versus‐host disease
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of grade II‐IV acute graftversus‐host disease
Endpoint domain: Adverse events/effects
Primary endpoint: FMA-U
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: MAL AOU
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: GAS-light
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: reliable deterioration
Endpoint domain: Adverse events/effects
Primary endpoint: patient empowerment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Axial length growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of pruritus vulvae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of vaginal discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of ESR, RF and CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: monitoring mother-infant relational health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Differences in extensor and flexor ITS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength ratios extensors/flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength ratios left flexors/right flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between SEMA-CD and SES-CD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-rater reliability for SEMA-CD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-rater reliability for SEMA-CD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-adjusted life years (QALYs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver HCCQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: US score accuracy in differentiating HAE from ICC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of mutans streptococci levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of lactobacilli levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety time of asphyxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in clinical and radiological periodontal parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the number of moderate and severe periodontitis sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimal clinically important difference on VAS scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Minimal clinically important difference on Oswestry scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Minimal clinically important difference on Laitinen scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: MKS as a continuous marker for risk of relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients achieving fT > MIC > 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean fT > MIC%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAI total scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: MFS improvements
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Safety and analgesic drug dose reduction
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number of patients with PIP of bronchodilator inhalers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: log-transformed fasting insulin (FINS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: log-transformed HOMA-β
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: State-Trait Anxiety Inventory (STAI-state)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: LKS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anatomical reduction in subtalar articular surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Bilateral activation in SMA and Pre-SMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: medial meniscus extrusion distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Appreciation of the final discussion with the radiologist
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perception of the radiologist's empathy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in Ln_RHI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum IL-12p40 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean MPOD at 0.25 degrees of retinal eccentricity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean MPOD at 0.50 degrees of retinal eccentricity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circulating proinflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cognitive ability recovery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cumulative rate of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Bowel Function Instrument score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Low anterior resection syndrome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of major low anterior resection syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pleasure felt during exercise
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: GMTs for antibodies against poliovirus types 1 and 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of epiretinal membranes
Endpoint domain: Adverse events/effects
Primary endpoint: reduced rates of moderate‐to‐severe asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased time‐to‐first moderate‐to‐severe asthma exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Primary PcP diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Discharge from hospital without oxygen within 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: externalizing problems in early adolescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SⅠT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BUT values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: distance passed to other pedestrian
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: α-diversity of intestinal microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abundance of Bifidobacterium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak expiratory flow rates (PEFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: new organ failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-index for RAP prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healing rate of corneal ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of ulcers over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief of postoperative constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: margin-negative resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: academic functioning
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Percentage reduction in pNfL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity for IRDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity for IRDs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PFM strength/endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P‐QoL‐role limitations
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cystocele stages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-Chair Stand test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence and grades of Oral Mucositis (OM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chewing
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Risk of developing Hodgkin lymphoma
Endpoint domain: Mortality/survival
Primary endpoint: re-dislocations
Endpoint domain: Mortality/survival
Primary endpoint: Mean SMFA score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Healthy Eating Index (HEI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate + vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival to day 30
Endpoint domain: Mortality/survival
Primary endpoint: Mean Hbmass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean V̇O2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3000 m running time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency response times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurodevelopmental delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: socioemotional outcome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Shoulder and neck disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic efficacy against UC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention in methadone treatment
Endpoint domain: Mortality/survival
Primary endpoint: Urine-verified methadone adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in substance use frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of SPH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality of Life (QoL) at 3-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physical functioning at 6-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Role functioning at discharge
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: pain level during movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: energy subscale SF-36
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Improvements in primary symptom categories of BD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean healing period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin roughness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: skin redness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: therapeutic efficacy of steroid injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: new documentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sharing plans with caregivers
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Urinary xylose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Effective rates of rash
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean FVC change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: device-oriented composite end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative oxycodone consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emergency department contact due to pain
Endpoint domain: Adverse events/effects
Primary endpoint: EBP knowledge and competencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in the mean number of TRPs at discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement of overall sleep status
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: low sense of wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: poor appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in MMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capacity to use patient portals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: β‐endorphin plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of unhealthy drinking habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction after education about bsDMARDs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: occlusal improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relieving abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reducing stool frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Elevations in GABA in the left striatum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurotransmitter outcomes
Primary endpoint: Reductions in [11C]‐raclopride binding potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurotransmitter outcomes
Primary endpoint: System Usability Scale (SUS) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incentive spirometry volume recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medical TCE performance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MA/A use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean D1MFT increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Mean D2MFT increment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: incremental AUC for triacylglycerol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in MRI-PDFF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to loss of consciousness (LoC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CIN
Endpoint domain: Adverse events/effects
Primary endpoint: visual evaluation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NMSE results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response time of emotional judgement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right thalamic activation in auditory emotional processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in A‐aDo2 at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Day 3 high-quality embryos rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Inter-rater reliability of MFRRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-rater reliability of MFRRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concurrent validity of MFRRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Needle passes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AHI response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FOSQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Interval from abortion to initiation (IAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Misoprostol requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of IED
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: QoLIE-89 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 5-year GOS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-month GOS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of stress and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in comfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Perceived cognitive benefit
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-regulation of mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ICIQ‐OAB symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ICIQ‐UI‐SF symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LVEF deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Grade ≥3 cardiac dysfunction
Endpoint domain: Adverse events/effects
Primary endpoint: Energy reliance on fat oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycogen replenishment in skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in circulating metabolomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in lipidomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: undesirable weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite outcome of coronary heart disease death, myocardial infarction, stroke, hospitalization for acute coronary syndrome, or coronary or cerebral revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Composite endpoint of coronary heart disease death, myocardial infarction, and stroke
Endpoint domain: Mortality/survival
Primary endpoint: number of packed red blood cell transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: time to install a pelvic binder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean tear film breakup time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: meibomian gland secretion score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean eye dryness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer hypoglycemic events (<70 mg/dL) per patient
Endpoint domain: Adverse events/effects
Primary endpoint: Fewer clinically significant hypoglycemic events (<54 mg/dL) per patient
Endpoint domain: Adverse events/effects
Primary endpoint: Lower percentage of time spent below range <70 mg/dL
Endpoint domain: Adverse events/effects
Primary endpoint: AEMG, peak value, IEMG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes